INSERM, Etablissement Français du Sang (EFS) Grand Est, BPPS UMR_S 1255, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
Transfusion. 2021 Mar;61(3):919-930. doi: 10.1111/trf.16280. Epub 2021 Feb 1.
Deterioration in quality of platelet concentrates (PCs) during storage results from the appearance of storage lesions affecting the hemostatic functions and posttransfusion survival of platelets. These lesions depend on the preparation and pathogen inactivation methods used, duration of storage, and platelet additive solutions (PASs) present in storage bags.
We investigated the effects of citrate contained in third-generation PAS (PAS-III) on storage lesions in buffy-coat PCs with or without photochemical (amotosalen-ultraviolet A) treatment over 7 days.
Platelet counts were conserved in all groups during storage, as was platelet swirling without appearance of macroscopic aggregates. Glycoprotein (GP) IIbIIIa and GPVI expression remained stable, whereas GPIbα declined similarly in all groups during storage. Removal of citrate from PAS-III, resulting in global reduction of citrate from 11 to 5 mM, led to a significant decrease in glucose consumption, which largely countered a modest deleterious effect of photochemical treatment. Citrate reduction also resulted in decreased lactate generation and better maintenance of pH during storage, while photochemical treatment had no impact on these parameters. Moreover, citrate-free storage significantly reduced exposure of P-selectin and the apoptosis signal phosphatidylserine, thereby abolishing the activating effect of photochemical treatment on both parameters. Citrate reduction benefited platelet aggregation to various agonists up to Day 7, whereas PCT had no impact on these responses.
Removal of citrate from PAS-III has a beneficial impact on platelet metabolism, spontaneous activation, and apoptosis, and improves platelet aggregation, irrespective of photochemical treatment, which should allow transfusion of platelets with better and longer-lasting functional properties.
储存过程中血小板浓缩物(PCs)质量的恶化是由于出现影响血小板止血功能和输注后存活的储存损伤所致。这些损伤取决于所使用的制备和病原体灭活方法、储存时间以及储存袋中的血小板添加剂溶液(PAS)。
我们研究了第三代 PAS(PAS-III)中所含的柠檬酸盐对未经或经光化学(氨甲喋呤-紫外线 A)处理的浓缩血小板在 7 天内储存损伤的影响。
在整个储存过程中,所有组的血小板计数均得到保存,血小板旋转也没有出现宏观聚集。糖蛋白(GP)IIbIIIa 和 GPVI 表达保持稳定,而 GPIbα 在整个储存过程中也以相似的方式下降。从 PAS-III 中去除柠檬酸盐,导致柠檬酸从 11 减少到 5 mM,导致葡萄糖消耗显著减少,这在很大程度上抵消了光化学处理的适度有害影响。柠檬酸减少还导致乳酸生成减少,储存过程中 pH 值更好地维持,而光化学处理对这些参数没有影响。此外,无柠檬酸储存可显著减少 P-选择素和凋亡信号磷脂酰丝氨酸的暴露,从而消除光化学处理对这两个参数的激活作用。柠檬酸减少有利于各种激动剂诱导的血小板聚集至第 7 天,而 PCT 对这些反应没有影响。
从 PAS-III 中去除柠檬酸盐对血小板代谢、自发性激活和凋亡有有益影响,并改善血小板聚集,无论是否进行光化学处理,这都应允许输注具有更好和更持久功能特性的血小板。